Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3502 |
|
| Actual shortage: | 231 (7%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3257 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
31 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-NAPROXEN | 500MG | TABLET | Resolved | 2024-10-31 | 2025-02-07 | 241688 |
| APO-FLECAINIDE | 100MG | TABLET | Resolved | 2024-10-31 | 2024-12-13 | 241691 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2024-10-31 | 2024-11-15 | 241694 |
| APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Resolved | 2024-10-31 | 2024-11-29 | 241697 |
| APO-ARIPIPRAZOLE | 15MG | TABLET | Resolved | 2024-11-07 | 2024-11-29 | 242199 |
| APO-CLONAZEPAM | 2MG | TABLET | Resolved | 2024-11-07 | 2025-02-14 | 242202 |
| APO-METOPROLOL (TYPE L) | 50MG | TABLET | Resolved | 2024-11-07 | 2024-12-06 | 242205 |
| APO-PERINDOPRIL | 4MG | TABLET | Resolved | 2024-11-07 | 2024-11-15 | 242208 |
| APO-RISPERIDONE | 1.0MG | TABLET | Resolved | 2024-11-07 | 2025-02-21 | 242214 |
| APO-IMATINIB | 100MG | TABLET | Resolved | 2024-11-14 | 2025-01-17 | 243083 |
| APO-ONDANSETRON | 4MG | TABLET | Resolved | 2024-11-15 | 2024-11-22 | 243181 |
| ALYSENA 28 | 20MCG 100MCG | TABLET | Resolved | 2024-11-15 | 2025-01-10 | 243184 |
| APO-ALLOPURINOL TABLETS | 300MG | TABLET | Resolved | 2024-11-15 | 2024-11-29 | 243187 |
| APO-ROSUVASTATIN | 40MG | TABLET | Resolved | 2024-11-15 | 2025-02-14 | 243190 |
| APO-GABAPENTIN | 800MG | TABLET | Resolved | 2024-11-21 | 2025-05-23 | 243620 |
| APO-CLOPIDOGREL | 300MG | TABLET | Resolved | 2024-11-21 | 2025-01-03 | 243623 |
| APO-FLECAINIDE | 50MG | TABLET | Resolved | 2024-11-29 | 2024-12-13 | 244200 |
| APO-CINACALCET | 30MG | TABLET | Resolved | 2024-11-29 | 2024-12-20 | 244203 |
| APO-DESMOPRESSIN | 0.2MG | TABLET | Resolved | 2024-12-05 | 2025-01-31 | 244883 |
| APO-DAPAGLIFLOZIN-METFORMIN | 850MG 5MG | TABLET | Resolved | 2024-12-05 | 2024-12-13 | 244918 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94446 | ||
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94449 | ||
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94452 | ||
| APO-HYDROCHLOROTHIAZIDE | Discontinued | 2019-11-26 | 2019-11-26 | 99653 | ||
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-CARBAMAZEPINE | Discontinued | 2020-02-19 | 2020-02-19 | 106679 | ||
| APO-NIZATIDINE | 150MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1127 |
| APO-NIZATIDINE | 300MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1135 |
| APO-NORTRIPTYLINE | 10MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1145 |
| APO-NORTRIPTYLINE | 25MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1155 |
| APO-GEMFIBROZIL CAP 300MG USP | 300MG | CAPSULE | Discontinued | 2017-03-31 | 2018-12-07 | 4920 |
| APO-DOCUSATE SODIUM | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2019-03-29 | 40733 |
| DOCUSATE SODIUM CAPSULES | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2018-09-15 | 40738 |
| APO-AMOXI | 250MG | CAPSULE | Discontinued | 2018-09-07 | 2019-02-13 | 60171 |
| APO-AMOXI | 500MG | CAPSULE | Discontinued | 2018-09-07 | 2018-11-09 | 60174 |
| APO-ATOMOXETINE | 60MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60273 |
| APO-CELECOXIB | 100MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-11 | 60363 |
| APO-CELECOXIB | 200MG | CAPSULE | Discontinued | 2018-09-07 | 2021-01-21 | 60366 |
| APO-CLINDAMYCIN | 150MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-28 | 60396 |
| APO-CLINDAMYCIN | 300MG | CAPSULE | Discontinued | 2018-09-07 | 2019-07-13 | 60399 |